{
    "title": "AbbVie sees substantial hit to Botox from pandemic, lowers Humira growth forecast",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8277849/Abbvie-stands-2020-profit-forecast-Humira-fuels-quarterly-beat.html",
    "date": "2020-05-01",
    "keywords": [
        "company",
        "coronavirus",
        "chander",
        "botox",
        "month",
        "business",
        "gonzalez",
        "abbvie",
        "drug",
        "quarter",
        "market",
        "health",
        "share",
        "inc",
        "friday",
        "outbreak",
        "drugmaker",
        "buyout",
        "blockbuster",
        "wrinkle",
        "treatment",
        "deal",
        "allergan",
        "contact",
        "spread",
        "recovery",
        "europe",
        "impact",
        "officer",
        "richard",
        "conference",
        "call",
        "profit",
        "street",
        "strength",
        "flagship",
        "medicine",
        "humira",
        "competition",
        "biosimilar",
        "patent",
        "protection",
        "part",
        "reason",
        "acquisition",
        "forecast",
        "growth",
        "crisis",
        "government",
        "insurance",
        "doctor",
        "refinitiv",
        "day",
        "reporting",
        "bengaluru",
        "carl",
        "york",
        "editing",
        "shinjini",
        "ganguli",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}